Expanding the universe of druggable targets with AI-powered protein design

Our founders developed the first protein language models in George Church's Lab and founded the company to combine generative models with massively multiplex experiments to design protein based therapies for applications where traditionally discovery has shown limited success.

We're a small, technical, fully in-person team motivated to advance drug design through the development of new AI and experimental technologies. We're a mix of machine learning and wet-lab scientists, and value science and engineering above all else.